Eugene Sun
Keine laufenden Positionen mehr
Profil
Eugene Sun served as the Chief Executive Officer & Director at Melinta Subsidiary Corp.
from 2015 to 2017.
He was also the Independent Director at NVN Liquidation, Inc. from 2018 to 2020.
Prior to that, he was the VP-Global Pharmaceutical Clinical Development at Abbott Laboratories from 2000 to 2011 and the Director at TAP Pharmaceutical Products, Inc. in 2008.
Dr. Sun received his undergraduate degree from Harvard University and his doctorate from New York University School of Medicine.
Ehemalige bekannte Positionen von Eugene Sun
| Unternehmen | Position | Ende |
|---|---|---|
| NVN LIQUIDATION, INC. | Direktor/Vorstandsmitglied | 29.01.2020 |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Vorstandsvorsitzender | 01.01.2017 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 24.08.2012 |
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Direktor/Vorstandsmitglied | 01.01.2008 |
Ausbildung von Eugene Sun
| Harvard University | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| NVN LIQUIDATION, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Health Technology |
